SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

ZATELLI, Maria Chiara
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 29.901
AS - Asia 15.544
EU - Europa 14.328
SA - Sud America 2.435
Continente sconosciuto - Info sul continente non disponibili 624
AF - Africa 327
OC - Oceania 29
Totale 63.188
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 29.138
FI - Finlandia 6.237
SG - Singapore 5.926
CN - Cina 3.680
IT - Italia 1.927
DE - Germania 1.915
BR - Brasile 1.879
VN - Vietnam 1.656
HK - Hong Kong 1.276
UA - Ucraina 1.165
GB - Regno Unito 791
TR - Turchia 728
BD - Bangladesh 686
FR - Francia 506
RU - Federazione Russa 489
JP - Giappone 404
CA - Canada 356
SE - Svezia 351
IN - India 318
PL - Polonia 309
MX - Messico 246
AR - Argentina 208
ID - Indonesia 206
NL - Olanda 154
ZA - Sudafrica 126
IQ - Iraq 104
PK - Pakistan 101
ES - Italia 96
EC - Ecuador 83
CO - Colombia 74
AT - Austria 64
BE - Belgio 61
VE - Venezuela 58
UZ - Uzbekistan 53
MY - Malesia 50
LT - Lituania 49
PH - Filippine 46
SA - Arabia Saudita 46
CL - Cile 44
MA - Marocco 43
AE - Emirati Arabi Uniti 34
JM - Giamaica 30
KE - Kenya 30
CR - Costa Rica 29
IE - Irlanda 29
PY - Paraguay 27
TN - Tunisia 26
AU - Australia 25
JO - Giordania 24
UY - Uruguay 24
EG - Egitto 23
PE - Perù 22
DZ - Algeria 20
AL - Albania 19
IL - Israele 19
CH - Svizzera 18
NP - Nepal 18
CZ - Repubblica Ceca 16
DO - Repubblica Dominicana 16
HN - Honduras 16
AZ - Azerbaigian 14
DK - Danimarca 14
GR - Grecia 14
KR - Corea 14
LB - Libano 14
TH - Thailandia 14
ET - Etiopia 13
PS - Palestinian Territory 13
PT - Portogallo 13
RO - Romania 13
BO - Bolivia 12
GT - Guatemala 12
IR - Iran 12
LV - Lettonia 12
OM - Oman 12
PA - Panama 12
KZ - Kazakistan 11
TT - Trinidad e Tobago 11
EU - Europa 10
MD - Moldavia 9
PR - Porto Rico 9
BH - Bahrain 8
NG - Nigeria 8
SY - Repubblica araba siriana 8
BG - Bulgaria 7
GA - Gabon 7
HU - Ungheria 7
KG - Kirghizistan 7
SV - El Salvador 7
CY - Cipro 6
SK - Slovacchia (Repubblica Slovacca) 6
TW - Taiwan 6
AM - Armenia 5
AO - Angola 5
BB - Barbados 5
BY - Bielorussia 5
HR - Croazia 5
KH - Cambogia 5
RS - Serbia 5
XK - ???statistics.table.value.countryCode.XK??? 5
Totale 62.489
Salva come PNG Salva come JPEG
Città #
Helsinki 5.843
Ashburn 3.749
Singapore 3.720
San Jose 2.186
Woodbridge 2.086
Fairfield 1.883
Chandler 1.487
Jacksonville 1.276
Santa Clara 1.265
Hong Kong 1.261
Houston 1.254
Beijing 1.162
Council Bluffs 1.015
Ann Arbor 842
Seattle 761
Wilmington 709
Cambridge 627
New York 544
Ho Chi Minh City 537
Los Angeles 516
Dallas 449
Izmir 412
Tokyo 390
Hanoi 383
Nanjing 375
Munich 363
Princeton 313
Lauterbourg 308
Milan 301
Warsaw 298
Addison 276
Ferrara 261
São Paulo 206
Shanghai 194
Boardman 189
San Diego 187
Mexico City 165
Jakarta 141
Orem 131
Toronto 126
Buffalo 125
Turku 122
London 120
Shenyang 119
Nanchang 112
Atlanta 108
Rome 107
Chicago 105
Phoenix 103
Dearborn 101
Brooklyn 100
Chennai 99
Montreal 95
Bremen 94
Denver 94
Hefei 88
Tianjin 88
Hebei 85
San Francisco 83
Bologna 76
Da Nang 76
Moscow 73
Frankfurt am Main 72
Washington 72
Changsha 70
Haiphong 70
Boston 68
Johannesburg 68
The Dalles 63
Stockholm 61
Manchester 57
Mountain View 56
Jiaxing 55
Rio de Janeiro 53
Falls Church 52
Jinan 52
Amsterdam 50
Brussels 49
Nuremberg 49
Poplar 49
Baghdad 45
Guangzhou 45
Tashkent 45
Kunming 44
Falkenstein 43
Naples 42
Belo Horizonte 41
Hải Dương 40
Lappeenranta 39
Norwalk 39
Redwood City 38
Ankara 36
Mumbai 35
Biên Hòa 34
Quito 31
Brasília 29
Campinas 29
Charlotte 29
Tappahannock 29
Curitiba 28
Totale 42.171
Salva come PNG Salva come JPEG
Nome #
Metodo per modulare la proliferazione del carcinoma midollare della tiroide (MTC) 1.989
Composti farmaceutici che inibiscono la proliferazione di adenomi ipofisari e modi d’uso che ne derivano 1.963
Uso di inibitori delle Cicloossigenasi di tipo 2 come agenti atti a modificare la farmacoresistenza cellulare 1.961
Pituitary apoplexy and COVID-19 vaccination: a case report and literature review 1.079
Pituitary and COVID-19 vaccination: a systematic review 497
SRC homology-2-containing protein tyrosine phosphatase-1 restrains cell proliferation in human medullary thyroid carcinoma 438
Control of pituitary adenoma cell proliferation by somatostatin analogs, dopamine agonists and novel chimeric compounds 332
Applicability of laparoscopic approach to the resection of large adrenal tumours: a retrospective cohort study on 200 patients 309
8th edition of the AJCC/TNM staging system of thyroid cancer: What to expect (ITCO#2) 302
HypoparaNet: A Database of Chronic Hypoparathyroidism Based on Expert Medical-Surgical Centers in Italy 294
Effect of Everolimus on Cell Viability in Nonfunctioning Pituitary Adenomas 290
Evaluation of the Role of BRAFV600E Somatic Mutation on Papillary Thyroid Cancer Disease Persistence: A Prospective Study 288
Role of Ultrasonographic/Clinical Profile, Cytology, and BRAF V600E Mutation Evaluation in Thyroid Nodule Screening for Malignancy: A Prospective Study 283
Proposal for a novel management of indeterminate thyroid nodules on the basis of cytopathological subclasses 282
Cyclooxygenase-2 inhibitors prevent the development of chemoresistance phenotype in a breast cancer cell line by inhibiting glycoprotein p-170 expression 272
A novel germline CDKN1B mutation causing multiple endocrine tumors: clinical, genetic and functional characterization 271
Igf-I influences everolimus activity in medullary thyroid carcinoma 265
Cyclooxygenase-2 inhibitors reverse chemoresistance phenotype in medullary thyroid carcinoma by a permeability glycoprotein-mediated mechanism 262
Relevance of BRAF(V600E) Mutation Testing Versus RAS Point Mutations and RET/PTC Rearrangements Evaluation in the Diagnosis of Thyroid Cancer 262
An in vivo OctreoScan-negative adrenal pheochromocytoma expresses somatostatin receptors and responds to somatostatin analogs treatment in vitro 260
Cyclin D1 levels are involved in the resistance to m-TOR inhibitors in human bronchial carcinoids 257
Proteasomes and RARS modulate AIMP1/EMAP II secretion in human cancer cell lines 252
Everolimus as a new potential antiproliferative agent in aggressive human bronchial carcinoids 251
Are Evidence-Based Guidelines Reflected in Clinical Practice? An Analysis of Prospectively Collected Data of the Italian Thyroid Cancer Observatory 249
Selective activation of somatostatin receptor subtypes differentially modulates secretion and viability in human medullary thyroid carcinoma primary cultures: potential clinical perspectives. 247
Increase in Peripheral CD3-CD56brightCD16- Natural Killer Cells in Hashimoto's Thyroiditis Associated with HHV-6 Infection 246
Recettori della somatostatina e carcinoma midollare della tiroide: prospettive future. 246
BRAF V600E mutation analysis increases diagnostic accuracy for papillary thyroid carcinoma in fine-needle aspiration biopsies 245
Is there a correlation between BRAFV600 mutation, sentinel lymph node biopsy, pathological and clinical parameters in papillary thyroid carcinoma? 243
Predictors of Pituitary Dysfunction in Patients Surviving Ischemic Stroke 241
Inhibition of epithelial growth factor receptor can play an important role in reducing cell growth and survival in adrenocortical tumors 239
A consensus on the diagnosis and treatment of acromegaly comorbidities: An update 237
Effects of two mTOR inhibitors on in-vitro models of GH-secreting pituitary adenomas 236
Magmas Overexpression Inhibits Staurosporine Induced Apoptosis in Rat Pituitary Adenoma Cell Lines 236
Adrenal cavernous hemangioma: a case report 236
Functional characterization of a new deletion in CDKN1B 5'-UTR region 235
Allelic discrimination in the diagnosis of somatic BRAF V600E mutation on fine-needle aspiration biopsies 234
Early onset acromegaly associated with a novel deletion in CDKN1B 5'UTR region 234
Activation of the somatotropic axis by testosterone in adult men: evidence for a role of hypothalamic growth hormone (GH)- releasing hormone function 232
X-linked acrogigantism syndrome: clinical profile and therapeutic responses 232
The cytotoxic effect of sunitinib on human bronchial carcinoid cell lines and primary cultures is counteracted by EGF and IGF-1 but not by VEGF 232
Protein Kinase C Delta restrains growth in ACTH-secreting pituitary adenoma cells 231
Acute administration of human galanin in normal subjects reduces the potentiating effect of pyridostigmine-induced cholinergic enhancement on release of norepinephrine and pancreatic polypeptide 230
Presenza di HHV-6 in campioni tiroidei di pazienti con malattie autoimmuni della tiroide 229
RET mutation profile and variable clinical manifestations in a family with multiple endocrine neoplasia type 2A and Hirschsprung's disease 229
Evaluation of hormonal function in a series of incidentally discovered adrenal masses 226
mTOR, AKT, p70S6K and ERK1/2 levels predict sensitivity to mTOR and PI3K/mTOR inhibitors in human bronchial carcinoids 226
The mystery of Mont’e Prama: sculptures, acromegaly, and nuragic society 225
Virologic and immunologic evidence supporting an association between HHV-6 and Hashimoto’s thyroiditis 225
Three-Dimensional Primary Cell Culture: A Novel Preclinical Model for Pancreatic Neuroendocrine Tumors 224
Magmas, a Novel Over-Expressed Gene in Pituitary Rat Cell Lines and in Human Pituitary Adenomas: A New Pituitary Biomarker? 224
Radio-guided selective compartment neck dissection improves staging in papillary thyroid carcinoma: a prospective study on 345 patients with a 3-year follow-up. 223
Growth hormone receptor blockade inhibits growth hormone-induced chemoresistance by restoring cytotoxic-induced apoptosis in breast cancer cells independently of estrogen receptor expression 222
Pasireotide, a multiple somatostatin receptor subtypes ligand, reduces cell viability in non-functioning pituitary adenomas by inhibiting vascular endothelial growth factor secretion 221
Cabergoline reduces cell viability in non functioning pituitary adenomas by inhibiting Vascular Endothelial Growth Factor secretion 220
Identification of differentially expressed microRNAs by microarray: A possible role for microRNA genes in pituitary adenomas 219
Epidermal growth factor pathway as a possible target in the medical therapy of bronchial carcinoids 219
BRAFV600E analysis on fine needle aspiration biopsy increases diagnostic accuracy for papillary thyroid cancer in clinically unsuspected nodules 218
Growth hormone excess promotes breast cancer chemoresistance 218
Growth hormone induces chemoresistance in breast cancer cells 218
Efficacy and Safety of Teriparatide in Beta-Thalassemia Major Associated Osteoporosis: A Real-Life Experience 216
Involvement of PKCβ and PKCδ isoforms in TSH signaling pathway in thyroid cancer cell lines 216
Cushing in a Leaf: Endocrine Disruption From a Natural Remedy 216
N-carbamidoyl-4-((3-ethyl-2,4,4-trimethylcyclohexyl)methyl)benzamide enhances staurosporine cytotoxic effects likely inhibiting the protective action of Magmas toward cell apoptosis 216
Differential mTOR and PI3K Pathway Activation in Human Bronchial Carcinoids 213
Antiproliferative effects of somatostatin analogs in pituitary adenomas 209
EGF and IGF1 affect sunitinib activity in BP-NEN: New putative targets beyond VEGFR? 208
Characteristics of a nationwide cohort of patients presenting with isolated hypogonadotropic hypogonadism (IHH) 208
Neck paraganglioma and follicular lymphoma: A case report 208
Therapeutic concentrations of mitotane (o,p′-DDD) inhibit thyrotroph cell viability and TSH expression and secretion in a mouse cell line model 207
miR-15a and miR-16-1 down-regulation in pituitary adenomas 207
R171Q MEN1 polymorphism in patients presenting with hyperparathyroidism 207
Should aip gene screening be recommended in family members of FIPA patients with R16H variant? 206
Deletion of exons 1-3 of the MEN1 gene in a large Italian family causes the loss of menin expression 206
Acromegaly secondary to an incidentally discovered growth-hormone-releasing hormone secreting bronchial carcinoid tumour associated to a pituitary incidentaloma 205
Magmas, a Gene Newly Identified as Overexpressed in Human and Mouse ACTH-Secreting Pituitary Adenomas, Protects Pituitary Cells from Apoptotic Stimuli 205
IGF-I Proliferative Effects Are Inhibited by Targeting PKC in Human Endocrine Tumor Cells 205
An unusual association of hyperparathyroidism, ectopic GHRH secrection and bronchial carcinoid in a MEN1 family 205
Mitotane enhances doxorubicin cytotoxic activity by inhibiting P-gp in human adrenocortical carcinoma cells 205
MTOR inhibitors response and mTOR pathway in pancreatic neuroendocrine tumors 203
Magmas, a novel over-expressed gene in Pituitary rat cell lines and in human pituitary adenomas: a new pituitary bio marker? 202
A new VHL polymorphism in a big family from Ferrara 201
Chromogranin A as a marker of neuroendocrine neoplasia: An Italian Multicenter Study 200
HHV-6A in vitro infection of thyrocytes and T cells alters the expression of miRNA associated to autoimmune thyroiditis 199
Efficacy of tolvaptan treatment in a patient with syndrome of inappropriate antidiuresis (SIAD) after severe traumatic brain injury 198
Growth hormone receptor blockade inhibits growth hormone-induced chemoresistance by restoring cytotoxic-induced apoptosis in breast cancer cells independently of estrogen receptor expression. 198
Clinical value of different responses of serum thyroglobulin to recombinant human thyrotropin in the follow-up of patients with differentiated thyroid carcinoma 196
Unexpected activation of pituitary-adrenal axis in healthy young and elderly subjects during somatostatin infusion 195
A tool to predict survival in stage IV entero-pancreatic NEN 195
Efficacy, safety and adherence to treatment of teriparatide: an observational study 194
Growth Hormone differentially modulates chemoresistance in human endometrial adenocarcinoma cell lines 194
Aetiology, diagnosis and treatment of thalassemia-associated osteoporosis of the adult 193
VEGF autocrine secretion is enhanced by EGFR activation trough ERK1/2 phosphorylation in human adrenocortical carcinoma cell lines 193
Atypical femoral fractures as a complication of long-term bisphosphonate therapy 192
mTOR, p70S6K, AKT and ERK1/2 levels predict sensitivity to mTOR and PI3K/mTOR inhibitors in human bronchial carcinoids 192
Glucose metabolism alterations in acromegaly 191
Growth Hormone Enhances Breast Cancer Chemoresistance by Inhibiting JNK-Mediated Apoptosis 191
Impact of the SARS-CoV2 pandemic dissemination on the management of neuroendocrine neoplasia in Italy: a report from the Italian Association for Neuroendocrine Tumors (Itanet) 191
In vitro testing of new somatostatin analogs on pituitary tumor cells 189
Bronchial carcinoid response to mTOR inhibitors depends on mTOR expression levels 189
Totale 29.270
Salva come PNG Salva come JPEG
Categoria #
all - tutte 264.994
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 11.792
Totale 276.786
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.641 0 256 179 54 118 160 129 151 114 223 266 991
2022/20233.186 321 277 130 435 467 440 168 266 385 26 165 106
2023/20242.076 151 193 103 57 138 315 56 454 58 47 49 455
2024/20257.639 206 165 605 202 929 796 221 311 1.250 974 1.108 872
2025/202628.562 1.974 846 1.797 2.606 3.387 1.455 2.938 1.326 7.721 2.572 1.158 782
2026/20273.506 1.523 1.983 0 0 0 0 0 0 0 0 0 0
Totale 63.188